Apellis Pharmaceuticals Inc Earnings

Apellis Pharmaceuticals Inc’s revenue jumped 132.98% since last year same period to $458.58Mn in the Q3 2025. On a quarterly growth basis, Apellis Pharmaceuticals Inc has generated 156.92% jump in its revenue since last 3-months.

Apellis Pharmaceuticals Inc’s net profit jumped 475.52% since last year same period to $215.72Mn in the Q3 2025. On a quarterly growth basis, Apellis Pharmaceuticals Inc has generated 611.77% jump in its net profits since last 3-months.

Apellis Pharmaceuticals Inc’s net profit margin jumped 261.18% since last year same period to 47.04% in the Q3 2025. On a quarterly growth basis, Apellis Pharmaceuticals Inc has generated 299.2% jump in its net profit margins since last 3-months.

Apellis Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -0.44 - a -17.34% fall from last quarter’s estimates.

Apellis Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -0.44.

Apellis Pharmaceuticals Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Apellis Pharmaceuticals Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.